• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度患者的急性早幼粒细胞白血病生物学特性与西方患者是否不同?

Does acute promyelocytic leukemia in Indian patients have biology different from the West?

作者信息

Dutta Pankhi, Sazawal Sudha, Kumar Rajat, Saxena Renu

机构信息

Department of Haematology, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Indian J Pathol Microbiol. 2008 Jul-Sep;51(3):437-9. doi: 10.4103/0377-4929.42555.

DOI:10.4103/0377-4929.42555
PMID:18723985
Abstract

Acute promyelocytic leukemia (APML) is a well-characterized malignancy with typical clinico-hematological and molecular features. However, Indian data on this malignancy are limited. This study was conducted to determine the clinico-hematological profile of APML in India. Thirty-five patients with APML presenting to Hematology Department, AIIMS, New Delhi, between July 2003 and June 2005 were evaluated for presenting clinical features, hemogram, peripheral smear, bone marrow morphology and cytochemistry. Reverse transcriptase PCR (RT-PCR) for PML-RARalpha was done in all cases. Male-to-female ratio was 0.9:1 (males--17 and females--18) with median age 25 years (range 11-57 years). Presenting features included anemia, bleeding, fever, gum hypertrophy and scrotal ulceration. All cases showed hypergranular abnormal promyelocytes. Median hemoglobin was 6.3 g/dL (range - 3.0-9.0 g/dL), total leukocyte count (TLC) was 33.88 x 10(9) /L (range - 1-170 x 10(9) /L). Platelet count was 28 x 10(9) /L (range - 4-170 x 10(9) /L). All cases were positive for myeloperoxidase and sudan black (SB), whereas 60% cases also showed non specific esterase (NSE) positivity with 40% cases being fluoride sensitive. RT-PCR showed PML-RARalpha in 33/35 cases with the bcr3 isoform being present in 24/33 positive cases (72.7%). The two cases negative for PML-RARalpha showed typical morphology and responded to ATRA. On statistical analysis, no correlation was found between bcr isoform and TLC, platelet count, age sex and early death. Unusual features included gum hypertrophy and scrotal ulceration at presentation and high median presenting TLC (33.8 x 10(9) /L). There was, however, no microgranular variant. Another interesting feature was a high incidence of NSE positivity (60%), which was fluoride sensitive in 40%. Moreover, the bcr3 isoform was significantly overexpressed (72.7%) in comparison to other studies. APML in India has certain unusual features, which may reflect a different biology.

摘要

急性早幼粒细胞白血病(APML)是一种具有典型临床血液学和分子特征的特征明确的恶性肿瘤。然而,关于这种恶性肿瘤的印度数据有限。本研究旨在确定印度APML的临床血液学特征。对2003年7月至2005年6月期间就诊于新德里全印度医学科学研究所血液科的35例APML患者进行了评估,包括其呈现的临床特征、血常规、外周血涂片、骨髓形态学和细胞化学检查。所有病例均进行了PML-RARα的逆转录酶聚合酶链反应(RT-PCR)。男女比例为0.9:1(男性17例,女性18例),中位年龄25岁(范围11 - 57岁)。呈现的特征包括贫血、出血、发热、牙龈肥大和阴囊溃疡。所有病例均显示颗粒增多的异常早幼粒细胞。中位血红蛋白为6.3 g/dL(范围 - 3.0 - 9.0 g/dL),白细胞总数(TLC)为33.88×10⁹/L(范围 - 1 - 170×10⁹/L)。血小板计数为28×10⁹/L(范围 - 4 - 170×10⁹/L)。所有病例髓过氧化物酶和苏丹黑(SB)均呈阳性,而60%的病例非特异性酯酶(NSE)也呈阳性,其中40%的病例对氟化物敏感。RT-PCR显示35例中有33例存在PML-RARα,24/33例阳性病例(72.7%)存在bcr3亚型。2例PML-RARα阴性病例表现出典型形态并对全反式维甲酸(ATRA)有反应。经统计学分析,未发现bcr亚型与TLC、血小板计数、年龄、性别及早期死亡之间存在相关性。不寻常的特征包括就诊时牙龈肥大和阴囊溃疡以及较高的就诊时TLC中位数(33.8×10⁹/L)。然而无微颗粒变异型。另一个有趣的特征是NSE阳性发生率较高(60%),其中40%对氟化物敏感。此外,与其他研究相比,bcr3亚型显著过度表达(72.7%)。印度的APML具有某些不寻常的特征,这可能反映了不同的生物学特性。

相似文献

1
Does acute promyelocytic leukemia in Indian patients have biology different from the West?印度患者的急性早幼粒细胞白血病生物学特性与西方患者是否不同?
Indian J Pathol Microbiol. 2008 Jul-Sep;51(3):437-9. doi: 10.4103/0377-4929.42555.
2
[Detection of PML/RARalpha gene transcripts in 46 newly diagnosed acute promyelocytic leukemia patients by real-time quantitative reverse-transcription polymerase chain reaction].[应用实时定量逆转录聚合酶链反应检测46例初诊急性早幼粒细胞白血病患者的PML/RARα基因转录本]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Feb;15(1):1-5.
3
Distribution of Different PML/RARα bcr Isoforms in Indian Acute Promyelocytic Leukemia (APL) Patients and Clinicohematological Correlation.印度急性早幼粒细胞白血病(APL)患者中不同 PML/RARα bcr 异构体的分布及其与临床血液学的相关性。
Mediterr J Hematol Infect Dis. 2014 Jan 2;6(1):e2014004. doi: 10.4084/MJHID.2014.004.
4
Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.急性早幼粒细胞白血病的微颗粒型和t(11;17)/PLZF-RARα变异型也呈现出PML-RARα基因重排所特有的CD13、CD34和CD15表达的流式细胞术模式。
Am J Hematol. 2004 May;76(1):44-51. doi: 10.1002/ajh.20055.
5
Acute promyelocytic leukemia M3: cytomorphologic, immunophenotypic, cytogenetic, and molecular variants.急性早幼粒细胞白血病M3:细胞形态学、免疫表型、细胞遗传学及分子变异型
J Hematother Stem Cell Res. 2002 Dec;11(6):941-50. doi: 10.1089/152581602321080600.
6
CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform.CD34 阳性急性早幼粒细胞白血病与白细胞增多、微颗粒/低颗粒形态、CD2 表达及 bcr3 亚型相关。
Am J Hematol. 2001 May;67(1):34-41. doi: 10.1002/ajh.1073.
7
Over-representation of bcr3 subtype of PML/RARalpha fusion gene in APL in Indian patients.印度患者急性早幼粒细胞白血病中PML/RARα融合基因bcr3亚型的过度表达。
Ann Hematol. 2005 Nov;84(12):781-4. doi: 10.1007/s00277-005-1095-4. Epub 2005 Nov 12.
8
Clinico-biological features and prognostic significance of PML/RARalpha isoforms in adult patients with acute promyelocytic leukemia treated with all trans retinoic acid (ATRA) and chemotherapy.全反式维甲酸(ATRA)联合化疗治疗的成年急性早幼粒细胞白血病患者中PML/RARα亚型的临床生物学特征及预后意义
Leuk Lymphoma. 2004 Mar;45(3):469-80. doi: 10.1080/10428190310001617295.
9
Cytochemical and immunophenotypic heterogeneity in acute promyelocytic leukemia.急性早幼粒细胞白血病中的细胞化学和免疫表型异质性。
Acta Haematol. 1989;81(1):5-9. doi: 10.1159/000205390.
10
Feasibility and clinical significance of real-time quantitative RT-PCR assay of PML-RARalpha fusion transcript in patients with acute promyelocytic leukemia.急性早幼粒细胞白血病患者中PML-RARα融合转录本实时定量逆转录聚合酶链反应检测的可行性及临床意义
Hematol J. 2001;2(5):330-40. doi: 10.1038/sj.thj.6200128.

引用本文的文献

1
Clinico-Pathological Significance and Prognostic Impact of Various PML RARA Transcripts on Outcomes in Acute Promyelocytic Myeloid Leukemia (APML) Treated with Single Agent Arsenic Trioxide(ATO)- Insights from a Tertiary Cancer Center in South India.各种PML-RARA转录本对单药三氧化二砷(ATO)治疗的急性早幼粒细胞白血病(APML)患者预后的临床病理意义及预后影响——来自印度南部一家三级癌症中心的见解
Indian J Hematol Blood Transfus. 2025 Jan;41(1):69-74. doi: 10.1007/s12288-024-01828-5. Epub 2024 Aug 10.
2
Different Isoforms of PML-RARA Chimeric Protein in Patients with Acute Promyelocytic Leukemia: Survival Analysis per Demographic Characteristics, Clinicohematological Parameters, and Cytogenetic Findings.急性早幼粒细胞白血病患者中PML-RARA嵌合蛋白的不同异构体:根据人口统计学特征、临床血液学参数和细胞遗传学结果进行生存分析
Iran J Pathol. 2023;18(4):456-475. doi: 10.30699/IJP.2023.20007229.3145. Epub 2023 Dec 15.
3
Analysing "tear-drop" prints of acute promyelocytic leukemia (APML): immunophenotypic prognostication of APML by FCM.分析急性早幼粒细胞白血病(APML)的“泪滴状”印记:通过流式细胞术对APML进行免疫表型预后评估。
Am J Blood Res. 2021 Aug 15;11(4):446-457. eCollection 2021.
4
Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from India.急性早幼粒细胞白血病的分子异质性——来自印度的单中心经验
Mediterr J Hematol Infect Dis. 2018 Jan 1;10(1):e2018002. doi: 10.4084/MJHID.2018.002. eCollection 2018.
5
Acute promyelocytic leukaemia: looking through 'gums'.急性早幼粒细胞白血病:透过“牙龈”观察
BMJ Case Rep. 2016 Nov 30;2016:bcr2016217457. doi: 10.1136/bcr-2016-217457.
6
Distribution of Different PML/RARα bcr Isoforms in Indian Acute Promyelocytic Leukemia (APL) Patients and Clinicohematological Correlation.印度急性早幼粒细胞白血病(APL)患者中不同 PML/RARα bcr 异构体的分布及其与临床血液学的相关性。
Mediterr J Hematol Infect Dis. 2014 Jan 2;6(1):e2014004. doi: 10.4084/MJHID.2014.004.
7
Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up.草药-矿物阿育吠陀疗法治疗一名二次复发的高危急性早幼粒细胞白血病患者:12年随访
J Ayurveda Integr Med. 2010 Jul;1(3):215-8. doi: 10.4103/0975-9476.72618.